D. Matthew Dorny - May 11, 2021 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
General Counsel
Signature
/s/ Gregory Belliston as Attorney-in-Fact for D. Matthew Dorny
Stock symbol
NUS
Transactions as of
May 11, 2021
Transactions value $
-$175,372
Form type
4
Date filed
5/12/2021, 06:32 PM
Next filing
Jun 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUS Class A Common Stock Options Exercise $190K +6.2K +12.61% $30.63 55.4K May 11, 2021 Direct
transaction NUS Class A Common Stock Sale -$164K -2.8K -5.06% $58.51 52.6K May 11, 2021 Direct F1, F2
transaction NUS Class A Common Stock Sale -$201K -3.4K -6.47% $59.25 49.2K May 11, 2021 Direct F1, F3
transaction NUS Class A Common Stock Gift $0 -2K -4.07% $0.00 47.2K May 11, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -6.2K -22.79% $0.00 21K May 11, 2021 Class A Common Stock 6.2K $30.63 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.90 to $58.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.05 to $59.60, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F4 Currently exercisable in full.